/OWLT
OWLT Stock - Owlet, Inc.
Healthcare|Medical - DevicesNYSE
$14.05+6.20%
+$0.82 (+6.20%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).71
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.50
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.3%upside
Target: $15.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OWLT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$13.91 – $14.19
TARGET (TP)$15.50
STOP LOSS$12.93
RISK/REWARD1:1.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.74
52W High$16.82
52W Low$2.75
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $78.06M | $54.01M | $69.20M | $75.84M | $75.40M |
| Gross Profit | $39.31M | $22.59M | $23.31M | $35.06M | $35.88M |
| Gross Margin | 50.4% | 41.8% | 33.7% | 46.2% | 47.6% |
| Operating Income | $-20,220,000 | $-28,632,000 | $-84,619,000 | $-55,792,000 | $-6,991,000 |
| Net Income | $-12,536,000 | $-32,901,000 | $-79,336,000 | $-71,704,000 | $-10,521,000 |
| Net Margin | -16.1% | -60.9% | -114.6% | -94.5% | -14.0% |
| EPS | $-0.83 | $-4.53 | $-9.97 | $-12.47 | $-5.12 |
Company Overview
Owlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Smart Sock, a baby monitor to track an infant's oxygen levels, heart rates, and sleep trends; Dream Sock, an app to assist children for better sleep; Cam, a video streaming app to hear and see baby from anywhere; and Dream Lab, an interactive online platform that assists families in building healthy sleep habits. The company also offers Dream Duo, a monitoring system for baby's sleeping habits and includes wearable sock monitor, HD video, and digital sleep coach. Owlet, Inc. was founded in 2012 and is based in Lehi, Utah.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
2 Bullish0 Neutral/Bearish
Price Targets
$7
Average Target
↓ 50.2% Downside
Now
$7
Low
$7
Average
$7
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 9th 2025 | William Blair | Initiation | Outperform | - |
| April 23rd 2025 | Northland Capital | Initiation | Outperform | $7 |
Earnings History & Surprises
OWLTBeat Rate
61%
Last 18 quarters
Avg Surprise
-6.6%
EPS vs Estimate
Beats / Misses
11/7
Last 12 quarters
Latest EPS
$0.03
Q4 2025
EPS Surprise History
Q1 24
-200.0%
$-0.12vs$-0.04
Q2 24
-178.6%
$-0.39vs$-0.14
Q3 24
+31.9%
$-0.13vs$-0.19
Q4 24
+112.5%
$0.03vs$0.01
Q1 25
+86.3%
$-0.07vs$-0.51
Q2 25
+74.1%
$-0.07vs$-0.27
Q3 25
+76.2%
$-0.05vs$-0.21
Q4 25
+113.0%
$0.03vs$-0.23
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 3, 2026 | $-0.26 | — | — | — |
Q4 2025 | Nov 13, 2025 | $-0.23 | $0.03 | +113.0% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $-0.21 | $-0.05 | +76.2% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $-0.27 | $-0.07 | +74.1% | ✓ BEAT |
Q1 2025 | Mar 4, 2025 | $-0.51 | $-0.07 | +86.3% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $0.01 | $0.03 | +112.5% | ✓ BEAT |
Q3 2024 | Aug 12, 2024 | $-0.19 | $-0.13 | +31.9% | ✓ BEAT |
Q2 2024 | May 6, 2024 | $-0.14 | $-0.39 | -178.6% | ✗ MISS |
Q1 2024 | Mar 7, 2024 | $-0.04 | $-0.12 | -200.0% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $-0.36 | $-0.70 | -94.4% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.72 | $-0.56 | +22.2% | ✓ BEAT |
Q2 2023 | May 11, 2023 | $-1.26 | $-1.12 | +11.1% | ✓ BEAT |
Q1 2023 | Mar 15, 2023 | $-2.24 | $-1.96 | +12.5% | ✓ BEAT |
Q4 2022 | Nov 14, 2022 | $-1.96 | $-2.38 | -21.4% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-2.52 | $-2.24 | +11.1% | ✓ BEAT |
Q2 2022 | May 11, 2022 | $-2.52 | $-2.38 | +5.6% | ✓ BEAT |
Q1 2022 | Mar 7, 2022 | $-2.38 | $-4.06 | -70.6% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $-0.98 | $-1.82 | -85.7% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-3.36 | $-4.20 | -25.0% | ✗ MISS |
Q2 2021 | May 27, 2021 | — | $-4.95 | — | — |
Latest News
Watching Owlet; Hearing Zacks HomeRun Newsletter Picks Stock
➖ NeutralBenzinga•Dec 19, 2025, 03:45 PM
Owlet Partners With 1 Natural Way To Expand DME Access For Families, Strengthening Medicaid And TRICARE Coverage
📈 PositiveBenzinga•Dec 18, 2025, 01:52 PM
William Blair Initiates Coverage On Owlet with Outperform Rating
📈 PositiveBenzinga•Dec 9, 2025, 07:32 PM
Owlet shares are trading higher. The company announced it filed for an offering of up to 5.35 million shares of its Class A common stock.
➖ NeutralBenzinga•Nov 24, 2025, 02:03 PM
Owlet Files For Offering Of Up To 5.35M Shares Of Class A Common Stock By The Selling Securityholders
➖ NeutralBenzinga•Nov 21, 2025, 09:07 PM
Owlet Non-GAAP EPS of $0.03 beats by $0.23, revenue of $32M beats by $5.18M
📈 PositiveSeeking Alpha•Nov 13, 2025, 09:29 PM
Owlet Raises FY2025 Sales Guidance from $97.000M-$100.000M to $103.000M-$106.000M vs $99.733M Est
📈 PositiveBenzinga•Nov 13, 2025, 09:20 PM
Owlet Q3 Adj. EPS $0.03 Beats $(0.20) Estimate, Sales $32.000M Beat $27.175M Estimate
📈 PositiveBenzinga•Nov 13, 2025, 09:19 PM
Owlet Announces Its New Video Monitor, Dream Sight, Is First Baby Monitor To Receive The SGS Cybersecurity Mark, A Global Certification Recognizing Top Standards In Cybersecurity And Privacy
📈 PositiveBenzinga•Oct 30, 2025, 12:52 PM
Owlet drops 12%, prices $30M equity at $7.15 per share
📉 NegativeSeeking Alpha•Oct 22, 2025, 06:16 AM
Owlet Announces Pricing Of Public Offering Of 4.2M Shares Of Class A Common Stock At $7.15 Per Share, Raising $30M In Gross Proceeds
➖ NeutralBenzinga•Oct 22, 2025, 05:48 AM
Owlet Offering Shares Of Class A Common Stock, Size Not Disclosed
➖ NeutralBenzinga•Oct 21, 2025, 09:15 PM
Owlet Announces India's Central Drugs Standard Control Organization Approves Its Dream Sock For Distribution
📈 PositiveBenzinga•Oct 15, 2025, 12:48 PM
Owlet Launches Medically-Certified Dream Sock In South Africa
📈 PositiveBenzinga•Sep 4, 2025, 12:46 PM
Shares are trading higher after the company announced its Dream Sock received certification from Australia's Therapeutic Goods Administration.
📈 PositiveBenzinga•Aug 21, 2025, 12:48 PM
Owlet's Dream Sock Earns Australia's Medical Device Certification, Advancing Global Infant Monitoring Access
📈 PositiveBenzinga•Aug 21, 2025, 12:46 PM
Frequently Asked Questions about OWLT
What is OWLT's current stock price?
Owlet, Inc. (OWLT) is currently trading at $14.05 per share. The stock has moved +6.20% today.
What is the analyst price target for OWLT?
The average analyst price target for OWLT is $15.50, based on 1 analyst.
What sector is Owlet, Inc. in?
Owlet, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NYSE exchange.
What is OWLT's market cap?
Owlet, Inc. has a market capitalization of $0.22 billion, making it a small-cap company.
Does OWLT pay dividends?
No, Owlet, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANIK
Anika Therapeutics, Inc.
$9.57
Mkt Cap: $0.1B
APLT
Applied Therapeutics, Inc.
$0.13
Mkt Cap: $0.0B
AVR
Anteris Technologies Global Corp.
$4.94
Mkt Cap: $0.2B
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$8.12
Mkt Cap: $0.1B
CRDF
Cardiff Oncology, Inc.
$2.57
Mkt Cap: $0.2B
ELTX
Elicio Therapeutics, Inc.
$7.94
Mkt Cap: $0.1B
LNSR
LENSAR, Inc.
$12.01
Mkt Cap: $0.1B
LUCD
Lucid Diagnostics Inc.
$1.12
Mkt Cap: $0.1B
MXCT
MaxCyte, Inc.
$1.50
Mkt Cap: $0.2B
RPID
Rapid Micro Biosystems, Inc.
$3.15
Mkt Cap: $0.1B
Explore stocks similar to OWLT for comparison